Herpes Zoster (Shingles) – Comprehensive Medical Guide

Overview

Herpes zoster, commonly known as shingles, is a painful skin rash caused by the reactivation of the varicella‑zoster virus (VZV), the same virus that causes chickenpox. After a person recovers from chickenpox, VZV remains dormant in sensory nerve ganglia. Years or decades later, the virus can reactivate, travel along the nerve to the skin, and produce a characteristic unilateral rash.

Most cases occur in adults over age 50, but shingles can affect anyone who has previously had chickenpox, including children and immunocompromised individuals.

Sources: Mayo Clinic, CDC

Symptoms Checklist

• Burning, tingling, or itching sensation on one side of the body
• Red rash that appears 3‑5 days after the pain begins
• Clusters of fluid‑filled blisters that follow a dermatome (band‑like pattern)
• Pain that may be mild to severe; can become chronic (post‑herpetic neuralgia)
• Fever, headache, fatigue, or general feeling of being unwell
• Swelling of affected lymph nodes
• Involvement of the eye (herpes zoster ophthalmicus) – redness, vision changes, eye pain
• Facial nerve involvement (Ramsay Hunt syndrome) – ear pain, facial weakness, hearing loss

Risk Factors

• Age ≥ 50 years (risk rises sharply after 60) [CDC]
• Weakened immune system (HIV/AIDS, cancer chemotherapy, organ transplant, long‑term steroids) [NIH]
• History of chickenpox (virtually everyone born before 1980) [Mayo Clinic]
• Chronic medical conditions (diabetes, chronic lung disease, rheumatoid arthritis) [Cleveland Clinic]
• Physical or emotional stress [Johns Hopkins]
• Female sex (slightly higher incidence) [CDC]

Diagnosis

Diagnosis is primarily clinical, based on the characteristic rash and pain distribution. The following tools may be used when the presentation is atypical:

• Physical examination: Visual inspection of the rash and assessment of dermatomal pattern.
• Polymerase chain reaction (PCR) testing: Swab of lesion fluid to detect VZV DNA – most sensitive.
• Direct fluorescent antibody (DFA) testing: Rapid identification of VZV in lesion specimens.
• Serology: Usually not needed, but can help differentiate from other viral infections.

For ocular involvement, an ophthalmologic exam with slit‑lamp evaluation is essential.

Sources: CDC – Diagnosis, Mayo Clinic

Treatment Options

Antiviral Medications (first‑line)

• Acyclovir 800 mg five times daily for 7‑10 days
• Valacyclovir 1 g three times daily for 7 days (more convenient dosing)
• Famciclovir 500 mg three times daily for 7 days

Antivirals are most effective when started within 72 hours of rash onset and can reduce pain severity, speed healing, and lower the risk of post‑herpetic neuralgia (PHN).

Pain Management

• Over‑the‑counter analgesics: acetaminophen or ibuprofen
• Prescription neuropathic agents: gabapentin, pregabalin, or tricyclic antidepressants (e.g., amitriptyline)
• Topical lidocaine patches or capsaicin cream for localized pain
• Short‑course oral corticosteroids (e.g., prednisone) may be considered in select patients to reduce acute inflammation, but they do not prevent PHN.

Home Care Measures

• Keep lesions clean and dry; gently wash with mild soap and water.
• Apply cool, wet compresses to relieve itching and pain.
• Wear loose‑fitting clothing to avoid friction on the rash.
• Use calamine lotion or oatmeal baths for soothing.
• Avoid scratching to reduce secondary bacterial infection.

Special Situations

• Ocular involvement: Immediate referral to an ophthalmologist; antiviral eye drops (e.g., trifluridine) may be added.
• Immunocompromised patients: Higher antiviral doses (e.g., acyclovir 10 mg/kg IV every 8 h) and longer treatment duration (14‑21 days).

Sources: Cleveland Clinic, Mayo Clinic

Prevention

• Vaccination:
  • Shingrix® (recombinant zoster vaccine, RZV) – two doses, 2‑6 months apart; >90 % efficacy in adults ≥50 y and immunocompromised adults.
  • Zostavax® (live attenuated vaccine, ZVL) – single dose; less effective and not recommended for immunocompromised patients.

  CDC recommends Shingrix for all adults ≥50 y and for adults ≥19 y with immunodeficiency, HIV, or undergoing immunosuppressive therapy.

• Maintain a healthy immune system: balanced diet, regular exercise, adequate sleep, stress management.
• Avoid close contact with individuals who have active shingles lesions, especially if you are immunocompromised.

Sources: CDC – Shingles Vaccination, NIH

Living With Herpes Zoster (Shingles)

• Track pain: Keep a daily pain diary to discuss with your provider, especially if pain persists beyond rash healing.
• Skin care: Use gentle, fragrance‑free moisturizers; change bandages daily if used.
• Nutrition: Foods rich in vitamin C, zinc, and B‑complex may support nerve healing.
• Physical activity: Light exercise (walking, stretching) can improve circulation and reduce stiffness.
• Psychological support: Chronic pain can affect mood; consider counseling or support groups if anxiety or depression develops.
• Follow‑up: Schedule a post‑treatment visit 2‑4 weeks after rash resolution to assess for PHN.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Severe eye pain, vision changes, redness, or swelling (possible herpes zoster ophthalmicus)
• Facial weakness, drooping, or hearing loss (Ramsay Hunt syndrome)
• Rapid spreading of rash beyond a single dermatome
• High fever (> 101.5 °F / 38.6 °C) with chills, severe headache, or stiff neck (signs of systemic infection)
• Signs of secondary bacterial infection: increasing redness, warmth, pus, or foul odor from lesions
• Sudden, severe, burning pain that is out of proportion to the rash (possible nerve involvement requiring urgent pain control)

Sources: Mayo Clinic, CDC